June 24, 2019
Newly Published Article Reporting Clinical Activity of Orally Administered OKT3, a Mouse Anti-CD3 Monoclonal Antibody, in Moderate to Severe Ulcerative Colitis Patients, Supports Tiziana’s Oral Monoclonal Antibody Platform
Third party research conducted by leading U.S. institutions to be published in a peer reviewed journal Crohn’s & Colitis 360…